Skip to main content
Log in

Association of the polymorphic markers G(−455)A in the FGB gene and C(−1654)T in the PROC gene with hereditary predisposition to unfavourable outcome in patients with history of acute coronary syndrome

  • Genomics and Transcriptomics
  • Published:
Molecular Biology Aims and scope Submit manuscript

Abstract

Associations of polymorphisms of genes FGB G(−455)A and PROC C(−1654)T with the frequency of poor outcomes in patients with the history of acute coronary syndrome (ACS) were studied in the Russian population. A total of 1145 patients admitted to cardiological hospitals of Moscow, St. Petersburg, Kazan, Chelyabinsk, Perm, Stavropol, and Rostov-on-Don with ischemic heart disease exacerbation were examined. The mean follow-up time was 1.14 ± 0.33 years, and the maximum follow-up time was 3.2 years. The risk of poor outcome did not depend on the carriership of genotypes of the polymorphic G(−455)A marker in the FGB gene. However, the PROC C(−1654)T polymorphism patients with ACS history and allele T of the PROC gene had a poor outcome more often than patients homozygous for allele C. The survival time to the endpoint for carriers of the TT and CT genotypes of the PROC gene was 2.19 ± 0.18 years vs. 2.46 ± 0.16 years for carriers of the CC genotype. On the base of these results it is suggested that hemostasis-related genes play an important role in early failures in patients with ACS history.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

IHD:

ischemic heart disease

MI:

myocardial infarction

LDL:

low-density lipoproteins

ACS:

acute coronary syndrome

CVD:

cardiovascular diseases

FGB:

gene coding β-chain of fibrinogen

PROC:

gene coding protein C.

References

  1. Oganov R.G., Maslennikova G.Ya. 2003. Impact of cardiovascular and other noninfectious diseases on population health in Russia. Serdtse. 2, 58–61.

    Google Scholar 

  2. Shevchenko O.P., Mishnev O.D. 2005. Ishemicheskaya bolezn’ serdtsa (Ischemic Heard Disease), Moscow: Reafarm.

    Google Scholar 

  3. Goyal A., Blazing M. 2005. Should we measure C-reactive protein levels to ascertain the adequacy of statin therapy in patients who are at very high risk for a coronary heart disease event? Am. Heart J. 150, 650–651.

    Article  PubMed  Google Scholar 

  4. Aronov D.A. 2002. Primary and secondary prophylaxis of cardiovascular diseases: Interpolation to Russia. Serdtse. 3, 109–112.

    Google Scholar 

  5. Pratt R.E., Dzau V.J. 1999. Genomics and hypertension: Concepts, potentials, and opportunities. Hypertension. 33, 238–247.

    CAS  PubMed  Google Scholar 

  6. Damani M.D., Topol M.D. 2007. Future use of genomics in coronary artery disease. J. Am. Coll. Cardiol. 50, 1933–1940.

    Article  CAS  PubMed  Google Scholar 

  7. Meade T.W., Mellows S., Brozovic M., et. al. 1986. Haemostatic function and ischemic heart disease: Principal results of the Horthwick Park Heart Stydy. Lancet. 2, 533–537.

    Article  CAS  PubMed  Google Scholar 

  8. van’t Hooft F.M., von Bahr S.J. 1999. Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration. Arterioscler. Thromb. Vasc. Biol. 19, 3063–3070.

    Google Scholar 

  9. Spek C.A., Koster T., Rosendaal F.R., et al. 1995. Genotypic variation in the promoter region of the protein C gene is associated with plasma protein C levels and thrombotic risk. Arterioscler. Thromb. Vasc. Biol. 15, 214–218.

    CAS  PubMed  Google Scholar 

  10. Bogaty P., Robitaille N.-M., Solymoss S., et al. 1998. Atherogenic, hemostatic, and other potential risk markers in subjects with previous isolated myocardial infarction compared with long-standing uncomplicated stable angina. Am. Heart J. 136, 884–893.

    Article  CAS  PubMed  Google Scholar 

  11. Mathew C.G.P. 1984. The isolation of high molecular weight eukaryotic DNA. Methods Mol. Biol. 2, 31–34.

    CAS  Google Scholar 

  12. Green F., Hamster A., Blomback M., Humphries S. 1993. The role of beta-fobrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden. Thromb. Haemost. 70, 915–920.

    CAS  PubMed  Google Scholar 

  13. Folsom A.R., Aleksic N., Ahn C., et al. 2001. Betafibrinogen gene −455G/A polymorphism and coronary heart disease incidence: The atherosclerosis risk in communities (ARIC) study. Ann. Epidemiol. 11, 166–170.

    Article  CAS  PubMed  Google Scholar 

  14. Zee R.Y., Diehl K.A., Ridker P.M. 2005. Complement factor H Y402H gene polymorphism, C-reactive protein, and risk of incident myocardial infarction, ischaemic stroke, and venous thromboembolism: A nested case-control study. Atherosclerosis. 60, 126–136.

    Google Scholar 

  15. Sampaio M.F., Hirata M.H., Crespo H., et al. 2007. AMI is associated with polymorphisms in the NOS3 and FGB but not in PAI-1 genes in young adults. Clin. Chim. Acta. 377, 154–162.

    Article  CAS  PubMed  Google Scholar 

  16. Chudakova D.A., Minushkina L.O., Zateyshchikov D.A., Nosikov V.V. 2004. Association of polymorphic marker A1/A2 of gene ITGB3 with coronary artery disease and myocardial infarction. Genetika. 40, 1406–1409.

    CAS  PubMed  Google Scholar 

  17. Tybjaerg-Hansen A., Agerholm-Larsen B., Humphries S.E., Abildgaard S., Schnohr P., Nordestgaard B.G. 1997. A common mutation (G −455 → A) in the betafibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9127 individuals based on the Copenhagen City Heart Study. J. Clin. Invest. 99, 3034–3039.

    Article  CAS  PubMed  Google Scholar 

  18. Doggen C., Bertina R. 2000. Fibrinogen polymorphisms are not associated with the risk of myocardial infarction. Br. J. Haematol. 110, 935–943.

    Article  CAS  PubMed  Google Scholar 

  19. Zakirova V.B., Brovkin A.N., Galeeva Z.M., et al. 2008. Genetic predisposition to unfavorable course of ischemic heart disease in patients after acute coronary syndrom. Kardiologiya. 200, 13–18.

    Google Scholar 

  20. Martiskainen M., Pohjasvaara T., Mikkelsson J., et al. 2003. Fibrinogen gene promoter −455 A allele as a risk factor for lacunar stroke. Stroke. 34, 886–891.

    Article  CAS  PubMed  Google Scholar 

  21. Parfenov M.G., Titov B.V., Sudomoina M.A., Martynov M.Yu., Favorov A.V., Ochs M.F., Gusev E.I., Favorova O.O. 2009. Genetic susceptibility to ischemic stroke in Russians. Mol. Biol. 43, 873–880.

    Article  CAS  Google Scholar 

  22. Hoth T., Evans T.W. 2001. Activated protein C: The cure for sepsis — again? Anaesthesia. 56, 1133–1135.

    Article  CAS  PubMed  Google Scholar 

  23. Sidorkina A.N., Sidorkin V.G., Presnyakova M.V. 2001. Biokhimicheskie osnovy gemostaza i disseminirovannoe vnutrisosudistoe svertyvanie krovi (Biochemical Bases of Homeostasis and Disseminated Intravascular Blood Coagulation), Novgorod: NNIITO.

    Google Scholar 

  24. Aiach M., Nicaud V., Gelas M.A., et al. 1999. Complex association of protein C gene promoter polymorphism with circulating protein C levels and thrombotic risk. Arterioscler. Thromb. Vasc. Biol. 19, 1573–1576.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V. V. Nosikov.

Additional information

Original Russian Text © Yu.V. Agapkina, A.G. Nikitin, A.N. Brovkin, A.A. Pushkov, M.A. Evdokimova, O.Yu. Aseycheva, V.S. Osmolovskaya, L.O. Minushkina, M.S. Kochkina, N.D. Selezneva, E.N. Dankovtseva, O.S. Chumakova, T.N. Baklanova, P.A. Talyzin, N.E. Reznichenko, O.P. Donetskaya, S.N. Tereschenko, E.S. Krasil’nikova, N.A. Dzhaiani, E.V. Akatova, M.G. Glezer, A.S. Galyavich, V.B. Zakirova, N.A. Koziolova, I.V. Timofeeva, A.V. Yagoda, O.I. Boyeva, L.I. Katelnitskaya, E.V. Horolets, S.V. Shlyk, E.G. Volkova, M.P. Margaryan, I.O. Guz, V.O. Konstantinov, A.N. Timofeyeva, B.A. Sidorenko, D.A. Zateyshchikov, V.V. Nosikov, 2010, published in Molekulyarnaya Biologiya, 2010, Vol. 44, No. 4, pp. 613–619.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Agapkina, Y.V., Nikitin, A.G., Brovkin, A.N. et al. Association of the polymorphic markers G(−455)A in the FGB gene and C(−1654)T in the PROC gene with hereditary predisposition to unfavourable outcome in patients with history of acute coronary syndrome. Mol Biol 44, 541–545 (2010). https://doi.org/10.1134/S0026893310040060

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S0026893310040060

Key words

Navigation